Cargando…
The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma
Objectives: The value of chemotherapy in the survival benefits of patients aged > 40 years with osteosarcoma is controversial. We aimed to explore the impact of chemotherapy on the survival benefits of patients aged >40 years with osteosarcoma. Methods: The Surveillance, Epidemiology, and End...
Autores principales: | Cao, Zhiyou, Zhang, Yuelin, Xu, Qiang, Yu, Xiaolong, Liu, Xuqiang, Dai, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721374/ https://www.ncbi.nlm.nih.gov/pubmed/34918558 http://dx.doi.org/10.1177/15330338211066195 |
Ejemplares similares
-
Primary Osteosarcoma in Patients Older than 40 Years of Age
por: Jeon, Dae Geun, et al.
Publicado: (2006) -
Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival?
por: Ek, Eugene TH, et al.
Publicado: (2006) -
Therapeutic effect of neoadjuvant chemotherapy combined with curettage to treat distal femoral osteosarcoma: A case report
por: Lai, Qi, et al.
Publicado: (2017) -
Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
por: Pan, Yue, et al.
Publicado: (2019) -
Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
por: Wang, Jinkui, et al.
Publicado: (2023)